Skip to main content

Table 1 Clinical phenotypes of congenital ichthyosis (CI) cohort

From: Altered skin microbiome, inflammation, and JAK/STAT signaling in Southeast Asian ichthyosis patients

Clinical manifestations

Patients (# of CI subtype patients with clinical finding) (n = 36)

Frequency (%)

Hyperkeratosis (thick skin)

IV(15), HI(8), LI(3), EI(4), TTD(3), ARC(1), SLS(2)

100

Itch/Pruritus

IV(15), HI(8), LI(3), EI(4), TTD(3), ARC(1), SLS(1)

97.22

Skin microbial infection* (n = 18)

IV(9), HI(2), EI(1), TTD(2), SLS(1)

83.33

Erythroderma

IV(10), HI(8), LI(1), EI(4), TTD(2) SLS(1)

72.22

Respiratory comorbidities

IV(10), HI(3), EI(2), TTD(3), SLS(1)

52.78

Sepsis

IV(7), HI (6), LI(2), EI(1), TTD(3)

52.78

Collodion membrane at birth

IV(1), HI(8), LI(3)

33.33

Cardiomyopathy comorbidities

IV(4), HI (2), EI(2), TTD(3)

30.56

Blistering

HI(8), EI(2)

27.78

Loss of heat

HI(3), LI(1), EI(2)

16.67

  1. The total number of CI patients (n = 36) in our cohort were categorized as: ichthyosis vulgaris (IV, n = 15), harlequin ichthyosis (HI, n = 8), lamellar ichthyosis (LI, n = 3), epidermolytic ichthyosis (EI, n = 4), trichothiodystrophy (TTD, n = 3), arthrogryposis, renal dysfunction, and cholestasis (ARC) syndrome (n = 1), and Sjögren–Larsson syndrome (SLS, n = 2). *Only n = 18 patients involved in testing for this manifestation; data of microbial infection and loss of heat shown in Additional file 15: Tables S2 and Additional file 16: Table S3, respectively